Cite
HARVARD Citation
Blume‐Peytavi, U. et al. (2020). Long‐term safety and efficacy of trifarotene 50 μg/g cream, a first‐in‐class RAR‐γ selective topical retinoid, in patients with moderate facial and truncal acne. Journal of the European Academy of Dermatology and Venereology. pp. 166-173. [Online].